Suzhou, China

Hong Yang

This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Soochow University, Jiangsu Electric Power Company, Nari Technology Co., Ltd.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Yang. Retrieved from https://idiyas.com/inventor/hong-yang-5bb1047g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0

 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Inventor Hong Yang

Introduction

Hong Yang is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of medical technology, particularly in the development of innovative anti-tumor drug delivery systems. With a total of four patents to his name, Yang's work focuses on enhancing the efficacy and safety of cancer treatments.

Latest Patents

One of Hong Yang's latest patents is for an anti-tumor platinum-based drug mineralized protein nanoparticle. This invention includes a platinum drug and a protein, with the protein being selected from albumin, transferrin, hemoglobin, and low-density lipoprotein. The platinum drugs utilized in this formulation include cisplatin, iodoplatin, bromoplatin, oxaliplatin, carboplatin, or nedaplatin. The drug loading of these nanoparticles ranges from 1% to 50%.

Another notable patent is for a platinum sulfide protein nanoparticle that possesses near-infrared photothermal effects and multimodal imaging functions. This nanoparticle is prepared in an aqueous phase and exhibits ultra-small particle size and good stability. It integrates functions of near-infrared imaging, CT imaging, and thermal imaging, allowing for high sensitivity and resolution in tumor targeting. The nanoparticle aims to achieve efficient and safe tumor treatment through thermal ablation.

Career Highlights

Hong Yang has worked at esteemed institutions such as Soochow University and the State Grid Corporation of China. His experience in these organizations has contributed to his expertise in the field of medical innovations.

Collaborations

Yang has collaborated with notable colleagues, including Huabing Chen and Hengte Ke, to advance his research and development efforts.

Conclusion

Hong Yang's innovative work in the field of anti-tumor drug delivery systems showcases his commitment to improving cancer treatment methodologies. His patents reflect a deep understanding of both medical science and engineering, positioning him as a key figure in the ongoing fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…